Treating severe diseases as cancer in a precise and careful way is CLS’ driving force. Our exciting journey has started and we are continuously adding new skills and energy to our dynamic team. Do not hesitate to send in your CV to register your interest to our HR manager. When you submit your CV, you also give your consent according to our GDPR policy. You can contact us at any time and request that we delete your personal information.
Both abstracts provide the latest insights into the clinical use of focal laser ablation for prostate cancer, contributing to the ongoing development of minimally invasive cancer therapies.
On the 29th of August, CLS organized a training camp for our European distributors within urology and their Clinical Applications Specialists. During two intense days in Turin, Italy, the team learned a lot about the treatment of localized prostate cancer using the CLS TRANBERG® product portfolio, both in theory and in practice.
Now, when summer is approaching and we're all looking forward to enjoying some days off, it's time to sumarize the news from the first half of 2024.
Welcome to Clinical Laserthermia Systems.
Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!
Please choose your country or region
